{"id":"W2343275026","doi":"10.1016/j.jval.2015.03.1168","title":"Bevacizumab for front-Line Treatment of Epithelial Ovarian, Fallopian tube or Primary Peritoneal Cancer Patients With High Risk of Relapse: a Cost Effective option for Canadian Patients","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Roche (Canada); University of Calgary","funders":"","keywords":"Medicine; Bevacizumab; Ovarian cancer; Fallopian tube cancer; Oncology; Internal medicine; Fallopian tube; Debulking; Population; Chemotherapy; Carboplatin; Randomized controlled trial; Gynecology; Surgery; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002413883,0.0001726922,0.000398602,0.0004670711,0.0006527363,0.001087228,0.0005611,0.0005669911,0.01122454],"category_scores_gemma":[0.001326279,0.0001014431,0.0004900687,0.00058228,0.0002170573,0.0003999761,0.0003587789,0.0010138,0.000371438],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01117825,"about_ca_system_score_gemma":0.01783061,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.5042592,"about_ca_topic_score_gemma":0.8067151,"domain_scores_codex":[0.9997976,0.00003293908,0.000007081141,0.00001543393,0.00006761027,0.00007935349],"domain_scores_gemma":[0.9994929,0.00004527062,0.00004941802,0.00000616519,0.000097288,0.000308867],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.005294831,0.00070711,0.03886392,0.0009502143,0.0003294985,0.001167359,0.0001130004,0.001616911,0.003079199,0.004887183,0.1296151,0.8133757],"study_design_scores_gemma":[0.009828229,0.003828299,0.328241,0.003912068,0.0025731,0.006541828,0.001340408,0.01386546,0.003428417,0.008395437,0.6177964,0.0002493518],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.4509444,0.2115742,0.002784934,0.1863294,0.002711195,0.0008889143,0.007208806,0.0004668956,0.1370912],"genre_scores_gemma":[0.9105241,0.05230414,0.006591814,0.01134135,0.0008574828,0.0001109325,0.002512979,0.00004540429,0.01571175],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4957408,"threshold_uncertainty_score":0.9973207,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03015928708277696,"score_gpt":0.2989305540345795,"score_spread":0.2687712669518025,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}